Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines. - Wikidata - awgldk - TriplyDB

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines.

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines.

http://www.wikidata.org/entity/Q35138373

about

Statins for secondary prevention: clinical use in patients with acute coronary syndrome in Wales.

P2860

Q38759058-9585909F-4FEB-4AB6-BB8B-E7F930E04357

P2860

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines.

http://www.wikidata.org/entity/Q35138373

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Optimizing secondary preventio ...... cordance with NICE guidelines.

@ast

Optimizing secondary preventio ...... cordance with NICE guidelines.

@en

type

label

Optimizing secondary preventio ...... cordance with NICE guidelines.

@ast

Optimizing secondary preventio ...... cordance with NICE guidelines.

@en

prefLabel

Optimizing secondary preventio ...... cordance with NICE guidelines.

@ast

Optimizing secondary preventio ...... cordance with NICE guidelines.

@en

P1433

Q35138373-BA7D54E1-A52A-420A-83C0-662733DD6870

P1476

Q35138373-E9830B68-CEB9-4162-B8A2-3281FECC9AE8

P2093

Q35138373-1ECEBFF4-CAAB-4DAC-BDCB-58C47F1BE535

Q35138373-30E78D33-E68C-4AB3-883B-01F794B4083A

Q35138373-39105111-6605-4B3C-8BD2-2A6FBD0FC59C

Q35138373-47FC0A66-31FA-4D2A-8D69-EBF37F583B00

Q35138373-50A512D5-DC45-42C1-8F8B-9C21ABF32B87

Q35138373-855A59E7-115B-4B10-BC01-1A96394CF9EC

Q35138373-8F33006A-57BA-4D5A-AF41-8384F4F3DF80

Q35138373-B9B6C327-7C36-4D75-B7CF-973D71D41729

Q35138373-D7F3D0B5-243B-4833-875F-01F12F4EF7E2

P2860

Q35138373-1FB5C2EA-158E-4D4B-A784-3A0E96A38470

Q35138373-74E55697-625C-4ECA-9395-23A49F74E570

Q35138373-85855931-8E89-45F2-961E-A260C0CE3E1B

Q35138373-9828EB43-FE22-4988-A0A4-8F6297732A34

Q35138373-A33BADFF-5A6D-4BAB-82D3-C80BA843734F

Q35138373-B617224B-7218-4B97-8850-3D7C54894425

Q35138373-C04B0489-E173-45AD-999D-2471CDDE5B6F

Q35138373-CFD4E8D3-C52E-4D04-81B4-3ADE0391385E

Q35138373-E7798367-83B7-490D-A59F-4D2E5A1EAC84

P304

Q35138373-F7764F2C-513C-41FB-BE1D-66DA5E1358B5

P31

Q35138373-D8098481-1E1E-4E10-8815-CC27C30C2967

P356

Q35138373-B712FAF7-0668-49DA-B089-AC8A690B7D27

P433

Q35138373-3855E651-D5B9-4779-A6C3-A9877C59F57E

P478

Q35138373-86237A54-28B5-4784-9194-C1BC0DE5A394

P577

Q35138373-19FF46EF-D227-4EE1-A2FC-168364694265

P5875

Q35138373-8F2BB3F6-5B41-450A-A684-CD19685B06DE

P698

Q35138373-17A60B80-A101-42CE-9A24-F214B2E6465F

P932

Q35138373-B9C18169-BC82-41F1-B8BF-700F1A450A01

P356

SHORTS.2011.011027

P1433

JRSM short reports

P1476

Optimizing secondary preventio ...... cordance with NICE guidelines.

@en

P2093

Amreen Shakur

http://www.w3.org/2001/XMLSchema#string

Aran Selvakumaran

http://www.w3.org/2001/XMLSchema#string

Cholan Anandarajah

http://www.w3.org/2001/XMLSchema#string

Chris Yu

http://www.w3.org/2001/XMLSchema#string

Geraldine McElligott

http://www.w3.org/2001/XMLSchema#string

Ivan Cheung

http://www.w3.org/2001/XMLSchema#string

Mandeep Kaler

http://www.w3.org/2001/XMLSchema#string

Rameen Shakur

http://www.w3.org/2001/XMLSchema#string

Santron Sathasivam

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.

Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.

P304

63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/SHORTS.2011.011027

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51576862

http://www.w3.org/2001/XMLSchema#string

P698

21847445

http://www.w3.org/2001/XMLSchema#string

P932

3147237

http://www.w3.org/2001/XMLSchema#string